CXO Diaries episode 4: Enabling digital capabilities in a highly regulated environment for building Pharma 4.0

About the session

Digitalisation has enabled greater opportunities for innovation throughout the life-cycle of pharmaceutical products. There's a greater degree of connectivity and transparency, which has now imposed a closer and greater control over operations and quality, allowing faster decision-making. However, on the contrary, upgrading to Pharma 4.0 demands higher levels of security, owing to the increased vulnerability of interconnected automated systems.

See More See Less
Video not supported in your device
Up Next
Up Next
Suggested stories from YourStory TV

Driving Financial Inclusion in India through technology

The future of entertainment in the experience economy - Part I

Startup Incubation - Changing the game the world over

The future of SaaS logistics leveraging cloud computing

BigQuery with ML and Visualization

Querying "Big" through MongoDB Atlas and GCP